At the start of his career, Sunil Hingorani, MD, PhD, now at the Fred Hutchinson Cancer Research Center, had a life-altering experience in caring for a patient with pancreatic cancer. A grant from the AACR in 2005 led him into an investigation that changed his approach to the disease.
In 2008, an AACR Centennial Postdoctoral Fellowship Award enabled Heiko Enderling, PhD, to build a mathematical model that could explain some of the dynamics of cancer stem cells. This research yielded several other papers and helped Dr. Enderling compete for a position at Moffitt Cancer Center, where he currently serves as an Associate Professor, Integrated Mathematical Oncology, Radiation Oncology.
In 2003, Patrick Ma, MD, received the AACR-AstraZeneca-Cancer Research and Prevention Foundation fellowship and used it to study c-Met mutations in lung cancer and the therapeutic potential of targeting c-Met. He's now leader of the multidisciplinary thoracic oncology disease team at the Penn State Cancer Institute. Read how the AACR fellowship helped launch his career.
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type will survive for five years or more. Glioblastoma is notoriously difficult to treat, and new avenues for diagnosis and treatment are...
AACR grantee Yi Fan, PhD, shared how flexible funding from an AACR Judah Folkman Career Development Award allowed him to explore an unconventional angle of anti-vascular therapy; namely, targeting genetic endothelial transformation, to fight the deadliest of brain cancers.
A world-renowned physician-scientist in the field of renal cell carcinoma (RCC), W. Kimryn Rathmell, MD, PhD of Vanderbilt University Medical Center, offers to share the impact of two AACR-supported research grants on her career and research.
With a little help from the AACR, a fascination with cancer-associated viruses has turned into a successful career in research for Blossom Damania, PhD, of the University of North Carolina at Chapel Hill – a career that has gone global with research projects on four continents.
Kimberly Kelly, PhD, the CEO of a biotech startup called ZielBio, received an AACR-PanCAN Career Development Award for Pancreatic Cancer Research as one of the first grants of her independent academic career. The value of the grant, she says, is more than the money.